Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
GANX holding history
Gain Therapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GANX overviewAll 13F holders of GANXFull Q4 2025 holdings
- Shares (Q4 2025)
- 569,901
- Value
- $1.84M
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 569,901 | $1.84M | <0.1% | +35,549+6.7% | Added | Holders |
| Q3 2025 | 534,352 | $945.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 534,352 | $961.8K | <0.1% | +279,362+109.6% | Added | Holders |
| Q1 2025 | 254,990 | $487.0K | <0.1% | +77,915+44.0% | Added | Holders |
| Q4 2024 | 177,075 | $382.5K | <0.1% | +31,858+21.9% | Added | Holders |
| Q3 2024 | 145,217 | $258.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 145,217 | $185.9K | <0.1% | +25,853+21.7% | Added | Holders |
| Q1 2024 | 119,364 | $450.0K | <0.1% | +30,979+35.1% | Added | Holders |
| Q4 2023 | 88,385 | $288.6K | <0.1% | +18,105+25.8% | Added | Holders |
| Q3 2023 | 70,280 | $230.5K | <0.1% | +6,162+9.6% | Added | Holders |
| Q2 2023 | 64,118 | $287.2K | <0.1% | +11,513+21.9% | Added | Holders |
| Q1 2023 | 52,605 | $253.6K | <0.1% | +52,605 | New | Holders |